Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-12

Clinical Trial Update: Lapatinib in Combination With Vinorelbine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of lapatinib with vinorelbine in cancer has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lapatinib (Lapatinib)
  • Vinorelbine (Vinorelbine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-12-12